Literature DB >> 17242921

Test-retest stability of cerebral A1 adenosine receptor quantification using [18F]CPFPX and PET.

David Elmenhorst1, Philipp T Meyer, Andreas Matusch, Oliver H Winz, Karl Zilles, Andreas Bauer.   

Abstract

PURPOSE: The goal of the present study was to evaluate the reproducibility of cerebral A1 adenosine receptor (A1AR) quantification using [18F]CPFPX and PET in a test-retest design.
METHODS: Eleven healthy volunteers were studied twice. Eight brain regions ranging from high to low receptor binding were examined. [18F]CPFPX was injected as a bolus with subsequent infusion over 120 min. Various outcome parameters were compared based on either metabolite-corrected venous blood sampling [e.g. apparent equilibrium total distribution volume (DVt')] or a reference region [ratio of specific to non-specific distribution volume (BP2)].
RESULTS: Test-retest variability was low in the outcome measure BP2 (on average 5.9%) and moderate in DVt' (on average 13.2%). Regarding reproducibility, the outcome parameter BP2 showed an intra-class correlation coefficient (ICC) of 0.94 +/- 0.1. For DVt' the between-subject coefficient of variation (%CV) was similar to the within-subject %CV (around 10%), resulting in a poor ICC of 0.06 +/- 0.2.
CONCLUSION: Our results suggest that quantification of [18F]CPFPX imaging is reproducible and reliable for PET studies of the cerebral A1AR. Among the outcome parameters the non-invasive measures were of superior test-retest stability over the invasive.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17242921     DOI: 10.1007/s00259-006-0309-x

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN: 1619-7070            Impact factor:   9.236


  31 in total

1.  Synthesis and evaluation of no-carrier-added 8-cyclopentyl-3-(3-[(18)F]fluoropropyl)-1-propylxanthine ([(18)F]CPFPX): a potent and selective A(1)-adenosine receptor antagonist for in vivo imaging.

Authors:  Marcus H Holschbach; Ray A Olsson; Dirk Bier; Walter Wutz; Wiebke Sihver; Manfred Schüller; Bettina Palm; Heinz H Coenen
Journal:  J Med Chem       Date:  2002-11-07       Impact factor: 7.446

2.  Effect of age and smoking on in vivo CYP1A2, flavin-containing monooxygenase, and xanthine oxidase activities in Koreans: determination by caffeine metabolism.

Authors:  W G Chung; J H Kang; C S Park; M H Cho; Y N Cha
Journal:  Clin Pharmacol Ther       Date:  2000-03       Impact factor: 6.875

3.  Saturation analysis in PET--analysis of errors due to imperfect reference regions.

Authors:  J E Litton; H Hall; S Pauli
Journal:  J Cereb Blood Flow Metab       Date:  1994-03       Impact factor: 6.200

4.  Evaluation of the reference tissue models for PET and SPECT benzodiazepine binding parameters.

Authors:  Philippe Millet; Christophe Graf; Alfred Buck; Bernard Walder; Vicente Ibáñez
Journal:  Neuroimage       Date:  2002-10       Impact factor: 6.556

Review 5.  Functions of neuronal adenosine receptors.

Authors:  H L Haas; O Selbach
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2000-11       Impact factor: 3.000

6.  Evaluation of carbon-11 labeled KF15372 and its ethyl and methyl derivatives as a potential CNS adenosine A1 receptor ligand.

Authors:  J Noguchi; K Ishiwata; R Furuta; J Simada; M Kiyosawa; S Ishii; K Endo; F Suzuki; M Senda
Journal:  Nucl Med Biol       Date:  1997-01       Impact factor: 2.408

7.  Test-retest variability of serotonin 5-HT2A receptor binding measured with positron emission tomography and [18F]altanserin in the human brain.

Authors:  G S Smith; J C Price; B J Lopresti; Y Huang; N Simpson; D Holt; N S Mason; C C Meltzer; R A Sweet; T Nichols; D Sashin; C A Mathis
Journal:  Synapse       Date:  1998-12       Impact factor: 2.562

8.  Compartmental modeling of iodine-123-iodobenzofuran binding to dopamine D2 receptors in healthy subjects.

Authors:  M Laruelle; C van Dyck; A Abi-Dargham; Y Zea-Ponce; S S Zoghbi; D S Charney; R M Baldwin; P B Hoffer; H F Kung; R B Innis
Journal:  J Nucl Med       Date:  1994-05       Impact factor: 10.057

Review 9.  Adenosine and sleep-wake regulation.

Authors:  Radhika Basheer; Robert E Strecker; Mahesh M Thakkar; Robert W McCarley
Journal:  Prog Neurobiol       Date:  2004-08       Impact factor: 11.685

10.  In vivo imaging of adenosine A1 receptors in the human brain with [18F]CPFPX and positron emission tomography.

Authors:  Andreas Bauer; Marcus H Holschbach; Philipp T Meyer; Christian Boy; Hans Herzog; Ray A Olsson; Heinz H Coenen; Karl Zilles
Journal:  Neuroimage       Date:  2003-08       Impact factor: 6.556

View more
  10 in total

1.  Recovery sleep after extended wakefulness restores elevated A1 adenosine receptor availability in the human brain.

Authors:  David Elmenhorst; Eva-Maria Elmenhorst; Eva Hennecke; Tina Kroll; Andreas Matusch; Daniel Aeschbach; Andreas Bauer
Journal:  Proc Natl Acad Sci U S A       Date:  2017-04-03       Impact factor: 11.205

2.  Preclinical Evaluation of the First Adenosine A1 Receptor Partial Agonist Radioligand for Positron Emission Tomography Imaging.

Authors:  Min Guo; Zhan-Guo Gao; Ryan Tyler; Tyler Stodden; Yang Li; Joseph Ramsey; Wen-Jing Zhao; Gene-Jack Wang; Corinde E Wiers; Joanna S Fowler; Kenner C Rice; Kenneth A Jacobson; Sung Won Kim; Nora D Volkow
Journal:  J Med Chem       Date:  2018-11-13       Impact factor: 7.446

3.  Longitudinal assessment of cerebral 5-HT2A receptors in healthy elderly volunteers: an [18F]-altanserin PET study.

Authors:  Lisbeth Marner; Gitte M Knudsen; Steven Haugbøl; Søren Holm; William Baaré; Steen G Hasselbalch
Journal:  Eur J Nucl Med Mol Imaging       Date:  2008-10-01       Impact factor: 9.236

4.  Cerebral A1 adenosine receptors (A1AR) in liver cirrhosis.

Authors:  Christian Boy; Philipp T Meyer; Gerald Kircheis; Marcus H Holschbach; Hans Herzog; David Elmenhorst; Hans Juergen Kaiser; Heinz H Coenen; Dieter Haussinger; Karl Zilles; Andreas Bauer
Journal:  Eur J Nucl Med Mol Imaging       Date:  2007-11-14       Impact factor: 9.236

5.  Tracer kinetic modeling of [(11)C]AFM, a new PET imaging agent for the serotonin transporter.

Authors:  Mika Naganawa; Nabeel Nabulsi; Beata Planeta; Jean-Dominique Gallezot; Shu-Fei Lin; Soheila Najafzadeh; Wendol Williams; Jim Ropchan; David Labaree; Alexander Neumeister; Yiyun Huang; Richard E Carson
Journal:  J Cereb Blood Flow Metab       Date:  2013-08-07       Impact factor: 6.200

6.  Reproducibility of non-invasive a1 adenosine receptor quantification in the rat brain using [(18)F]CPFPX and positron emission tomography.

Authors:  Tina Kroll; David Elmenhorst; Angela Weisshaupt; Simone Beer; Andreas Bauer
Journal:  Mol Imaging Biol       Date:  2014-10       Impact factor: 3.488

7.  Effects of Long-Term Caffeine Consumption on the Adenosine A1 Receptor in the Rat Brain: an In Vivo PET Study with [18F]CPFPX.

Authors:  Danje Nabbi-Schroeter; David Elmenhorst; Angela Oskamp; Stefanie Laskowski; Andreas Bauer; Tina Kroll
Journal:  Mol Imaging Biol       Date:  2018-04       Impact factor: 3.488

8.  Association of adenosine receptor gene polymorphisms and in vivo adenosine A1 receptor binding in the human brain.

Authors:  Christa Hohoff; Valentina Garibotto; David Elmenhorst; Anna Baffa; Tina Kroll; Alana Hoffmann; Kathrin Schwarte; Weiqi Zhang; Volker Arolt; Jürgen Deckert; Andreas Bauer
Journal:  Neuropsychopharmacology       Date:  2014-06-19       Impact factor: 7.853

9.  Test-retest variability of adenosine A2A binding in the human brain with (11)C-TMSX and PET.

Authors:  Mika Naganawa; Masahiro Mishina; Muneyuki Sakata; Keiichi Oda; Mikio Hiura; Kenji Ishii; Kiichi Ishiwata
Journal:  EJNMMI Res       Date:  2014-12-29       Impact factor: 3.138

Review 10.  Purinergic Receptors of the Central Nervous System: Biology, PET Ligands, and Their Applications.

Authors:  Hamideh Zarrinmayeh; Paul R Territo
Journal:  Mol Imaging       Date:  2020 Jan-Dec       Impact factor: 4.488

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.